OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of anti-diabetic sodium-glucose cotransporter 2 inhibitors on tumor growth of intractable hematological malignancy in humans
Sawako Nakachi, Shiki Okamoto, Keita Tamaki, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112864-112864
Open Access | Times Cited: 8
Sawako Nakachi, Shiki Okamoto, Keita Tamaki, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112864-112864
Open Access | Times Cited: 8
Showing 8 citing articles:
Advances in sodium-glucose transporter protein 2 inhibitors and tumors
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Jiaqi Wang, Wenyong Yang
Frontiers in Oncology (2025) Vol. 15
Open Access
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 4
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 4
Effects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 3
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 3
Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?
Marco Gallo, Matteo Monami, Alberto Ragni, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110624-110624
Closed Access | Times Cited: 6
Marco Gallo, Matteo Monami, Alberto Ragni, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110624-110624
Closed Access | Times Cited: 6
Adenosine signaling: Optimal target for gastric cancer immunotherapy
Junqing Wang, Linyong Du, Xiangjian Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Junqing Wang, Linyong Du, Xiangjian Chen
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Deciphering the Causal Relationship between Sodium-glucose Cotransporter 2 Inhibition and Cancer Risks: A Comprehensive Mendelian Randomization Study
Liyin Zhang, Baorui Xue, Fangyang Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3903-3912
Open Access | Times Cited: 1
Liyin Zhang, Baorui Xue, Fangyang Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3903-3912
Open Access | Times Cited: 1
ML385, a selective inhibitor of Nrf2, demonstrates efficacy in the treatment of adult T-cell leukemia
Chie Ishikawa, Naoki Mori
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-12
Closed Access
Chie Ishikawa, Naoki Mori
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-12
Closed Access
Contemporary prospects for the use of sodium-glucose cotransporter-2 inhibitors
Anastasia R. Kondratieva, E. A. Khazova, Alina Vadimovna Lobanova, et al.
Perm Medical Journal (2024) Vol. 41, Iss. 6, pp. 92-108
Open Access
Anastasia R. Kondratieva, E. A. Khazova, Alina Vadimovna Lobanova, et al.
Perm Medical Journal (2024) Vol. 41, Iss. 6, pp. 92-108
Open Access
